Community-Acquired Pneumonia (CAP) Surveillance

Bayer

Status: Completed

Conditions: Pneumonia

Treatments: Other: No Drug

Study type: Observational

Funder types: Industry

Identifiers

NCT01416506

15465

NN1010CN (Other Identifier)

Details and patient eligibility

About

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Enrollment: 560 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chinese adult (male or female) ≥18 years old
• Outpatients or inpatients who suffer from CAP

Exclusion criteria

Trial design

560 participants in 1 patient group

Group 1

Treatment:

Other: No Drug